USC.edu
Are You a Patient?

John C. Lipham, MD

Professor of Clinical Surgery

Division Chief of Upper GI and General Surgery

Director, Foregut Cancer Program

Chief of USC Affiliated Academic Programs at Hoag Memorial Hospital

Image of John C. Lipham, MD
Is this your profile? Click to edit
Request an Appointment
Phone +1 714 288 8098
Email [email protected]
CTSI Profile

Overview

John C. Lipham, M.D. is Chief of the Division of Upper GI and General Surgery and Associate Professor of Surgery at the Keck School of Medicine of USC. Dr. Lipham also served as the Foregut Cancer Program Director and Chief of USC Affiliated Academic Programs at Hoag. He was instrumental in establishing the Hoag-USC Surgical Center for Digestive Diseases. He focuses on benign and malignant diseases of the esophagus and stomach. His clinical interests include the diagnosis and treatment of GERD, hiatal hernias, Barrett’s esophagus, esophageal motility disorders, achalasia, malignant diseases of the esophagus and stomach, and gastroparesis. His current research interests include developing minimally invasive methods of diagnosing and treating gastroesophageal reflux disease, Barrett’s, esophageal cancer and gastric cancer.

Publications

  • Education and training of surgical residents in upper gastrointestinal surgery: a European survey. Updates Surg. 2026 Feb; 78(1):55-62.. View in PubMed
  • Long-term (>5 Years) Outcomes after Magnetic Sphincter Augmentation. Ann Surg. 2026 06 01; 283(6):1001-1008.. View in PubMed
  • Utility of the mFI-5 as a predictor of post-operative outcomes following gastrectomy for gastric cancer: an ACS-NSQIP analysis. Surg Endosc. 2024 10; 38(10):5922-5928.. View in PubMed
  • Cruroplasty as a standalone treatment for recurrent hiatal hernia repair. Hernia. 2024 10; 28(5):1817-1822.. View in PubMed
  • Short term safety of magnetic sphincter augmentation vs minimally invasive fundoplication: an ACS-NSQIP analysis. Surg Endosc. 2024 04; 38(4):1944-1949.. View in PubMed
  • Trends and outcomes of intraoperative esophagogastroduodenoscopy during laparoscopic Heller myotomy: a National Surgical Quality Improvement Program analysis. J Gastrointest Surg. 2024 03; 28(3):282-284.. View in PubMed
  • Is Endoscopic Surveillance Needed After Laparoscopic Sleeve Gastrectomy? Curr Obes Rep. 2024 Mar; 13(1):183-185. Aiolfi A, Bona D, Lipham JC , Bonavina L . View in PubMed
  • Short-term Outcomes of Different Techniques for Gastric Ischemic Preconditioning Before Esophagectomy: A Network Meta-analysis. Ann Surg. 2024 Mar 01; 279(3):410-418.. View in PubMed
  • Antireflux Surgery Does Not Prevent Cancer in Barrett’s Esophagus. Gastroenterology. 2024 01; 166(1):21-23.. View in PubMed
  • Tumor differentiation impacts response to neoadjuvant therapy and survival in patients with esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2024 06; 167(6):1943-1950.. View in PubMed

Similar People